// App-Quantinova.ai

TCT CONNECT-16 : Implications of Impaired Coronary Flow on the Effects of Intracoronary Alteplase During Primary Percutaneous Coronary Intervention

Researchers

Presenter

  • Annette Maznyczka

Principal Investigators

  • Patrycja Duklas

  • John Greenwood

  • Douglas Muir

  • Saqib Chowdhary

  • Nick Curzen

  • Margaret McEntegart

  • Keith Oldroyd

  • Anthony Gershlick

  • Clare Appleby

  • Campbell Tait

  • James Cotton

  • Andrew Wragg

  • Naveed Sattar

  • Keith Fox

  • Hany Eteiba

  • Alex McConnachie

  • Colin Berry

Medical Centers

  • Barts Heart Centre, St. Bartholomew's Hospital, Barts Health National Health Service Trust, London, United Kingdom

  • Manchester Foundation Trust, Altrincham, United Kingdom

  • Leeds General Infirmary, Leeds, United Kingdom

  • Glasgow Royal Infirmary, Glasgow, United Kingdom

  • Robertson Centre of Biostatistics, University of Glasgow, Glasgow, United Kingdom

  • University Hospitals Leicester NHS Trust, Leicester, United Kingdom

  • Heart and Lung Centre, Wolverhampton, United Kingdom

  • University Hospital Southampton, Southampton, Hampshire, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

  • Golden Jubilee National Hospital, Clydebank, United Kingdom

  • The University of Edinburgh, Edinburgh, United Kingdom

  • Liverpool Heart & Chest NHS Foundation Trust, Liverpool, United Kingdom

  • James Cook University Hospital, Middlesborough, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • alteplase

  • Activase I.V.

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • NCT02257294

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved